留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

边缘供肝面临的机遇与挑战

鲁欣翼, 滕飞, 傅宏, 等. 边缘供肝面临的机遇与挑战[J]. 器官移植. doi: 10.3969/j.issn.1674-7445.2024002
引用本文: 鲁欣翼, 滕飞, 傅宏, 等. 边缘供肝面临的机遇与挑战[J]. 器官移植. doi: 10.3969/j.issn.1674-7445.2024002
Lu Xinyi, Teng Fei, Fu Hong, et al. Opportunities and challenges of marginal donor liver[J]. ORGAN TRANSPLANTATION. doi: 10.3969/j.issn.1674-7445.2024002
Citation: Lu Xinyi, Teng Fei, Fu Hong, et al. Opportunities and challenges of marginal donor liver[J]. ORGAN TRANSPLANTATION. doi: 10.3969/j.issn.1674-7445.2024002

边缘供肝面临的机遇与挑战

doi: 10.3969/j.issn.1674-7445.2024002
基金项目: 国家自然科学基金面上项目(82371792、81971503);医学免疫学国家重点实验室开放课题项目(NKLMI2023K03);海军军医大学校级基础医学研究课题项目(2022QN072)
详细信息
    作者简介:
    通讯作者:

    郭闻渊(ORCID 0000-0003-3313-3881),医学博士,主任医师,研究方向为肝移植及复杂肝脏外科手术学,Email:guowenyuan@smmu.edu.cn;毛家玺(ORCID 0000-0001-5006-6153),医学硕士,主治医师,研究方向为肝移植围手术期管理,Email:guowenyuan@smmu.edu.cn

  • 中图分类号: R617,R575

Opportunities and challenges of marginal donor liver

More Information
  • 摘要: 随着手术技术和术后免疫抑制治疗的不断突破与成熟,肝移植受者和移植物存活率显著提高,供肝短缺已成为限制肝移植临床发展的主要阻碍,如何扩大供肝来源也成为了当前迫切需要解决的问题。高龄供肝、脂肪变性供肝、病毒性肝炎供肝、心脏死亡器官捐献供肝等常见边缘供肝在临床肝移植中的使用已经取得了一定的突破性进展,但边缘供肝的使用仍存在较多限制。因此,本文对边缘供肝的定义,几种常见边缘供肝的应用及研究进展进行综述,探讨目前扩大肝移植供者池面临的机遇与挑战,旨在为临床肝移植供体池的扩大提供参考,造福更多终末期肝病患者。

     

  • [1] GOLDARACENA N, CULLEN JM, KIM DS, et al. Expanding the donor pool for liver transplantation with marginal donors[J]. Int J Surg, 2020, 82S: 30-35. DOI: 10.1016/j.ijsu.2020.05.024.
    [2] 王海波, 史赢, 周稚烨, 等. 2019年中国器官捐献与移植等待现状分析[J]. 中华器官移植杂志, 2021, 42(6): 324-325. DOI: 10.3760/cma.j.cn421203-20210108-00014.

    WANG HB, SHI Y, ZHOU ZY, et al. Analysis of organ donation and transplant waiting in China in 2019[J]. Chin J Organ Transplant, 2021, 42(6): 324-325. DOI: 10.3760/cma.j.cn421203-20210108-00014.
    [3] 汪恺, 高逢强, 徐骁. 拓展供肝来源的临床实践与若干思考[J]. 中华外科杂志, 2023, 61(10): 826-832. DOI: 10.3760/cma.j.cn112139-20230607-00228.

    WANG K, GAO FQ, XU X. The clinical practice and consideration for donor liver expansion[J]. Chin J Surg, 2023, 61(10): 826-832. DOI: 10.3760/cma.j.cn112139-20230607-00228.
    [4] GAO Q, MULVIHILL MS, SCHEUERMANN U, et al. Improvement in liver transplant outcomes from older donors: a US national analysis[J]. Ann Surg, 2019, 270(2): 333-339. DOI: 10.1097/SLA.0000000000002876.
    [5] SASS DA, REICH DJ. Liver transplantation in the 21st century: expanding the donor options[J]. Gastroenterol Clin North Am, 2011, 40(3): 641-658. DOI: 10.1016/j.gtc.2011.06.007.
    [6] 杨梦凡, 魏绪勇, 王琨, 等. 高龄供肝对肝移植术后并发症的影响——148例受者预后分析及思考[J/CD]. 实用器官移植电子杂志, 2020, 8(2): 101-105. DOI: 10.3969/j.issn.2095-5332.2020.02.006.

    YANG MF, WEI XY, WANG K, et al. The effect of elderly donor liver on the complications of recipient after liver transplantation--prognosis analysis and reflection of 148 patients[J/CD]. Pract J Organ Transplant (Electr Vers), 2020, 8(2): 101-105. DOI: 10.3969/j.issn.2095-5332.2020.02.006.
    [7] CHEDID MF, ROSEN CB, NYBERG SL, et al. Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors[J]. HPB (Oxford), 2014, 16(9): 852-858. DOI: 10.1111/hpb.12221.
    [8] HAUGEN CE, HOLSCHER CM, LUO X, et al. Assessment of trends in transplantation of liver grafts from older donors and outcomes in recipients of liver grafts from older donors, 2003-2016[J]. JAMA Surg, 2019, 154(5): 441-449. DOI: 10.1001/jamasurg.2018.5568.
    [9] HOUBEN P, BORMANN E, KNEIFEL F, et al. How old is old? an age-stratified analysis of elderly liver donors above 65[J]. J Clin Med, 2022, 11(13): 3899. DOI: 10.3390/jcm11133899.
    [10] HALAZUN KJ, RANA AA, FORTUNE B, et al. No country for old livers? examining and optimizing the utilization of elderly liver grafts[J]. Am J Transplant, 2018, 18(3): 669-678. DOI: 10.1111/ajt.14518.
    [11] JACKSON KR, MOTTER JD, HAUGEN CE, et al. Temporal trends in utilization and outcomes of steatotic donor livers in the United States[J]. Am J Transplant, 2020, 20(3): 855-863. DOI: 10.1111/ajt.15652.
    [12] DOYLE MB, VACHHARAJANI N, WELLEN JR, et al. Short- and long-term outcomes after steatotic liver transplantation[J]. Arch Surg, 2010, 145(7): 653-660. DOI: 10.1001/archsurg.2010.119.
    [13] CROOME KP, LEE DD, CROOME S, et al. Does donor allograft microsteatosis matter? comparison of outcomes in liver transplantation with a propensity-matched cohort[J]. Liver Transpl, 2019, 25(10): 1533-1540. DOI: 10.1002/lt.25583.
    [14] 肖扬, 尹明丽, 温新元. 脂肪肝在肝移植中的应用前景[J]. 中华肝胆外科杂志, 2022, 28(8): 628-632. DOI: 10.3760/cma.j.cn113884-20220315-00111.

    XIAO Y, YIN ML, WEN XY. Application prospect of fatty liver in liver transplantation[J]. Chin J Hepatobiliary Surg, 2022, 28(8): 628-632. DOI: 10.3760/cma.j.cn113884-20220315-00111.
    [15] ROSENFELD DM, SMITH ML, SEAMANS DP, et al. Fatal diffuse pulmonary fat microemboli following reperfusion in liver transplantation with the use of marginal steatotic allografts[J]. Am J Transplant, 2019, 19(9): 2640-2645. DOI: 10.1111/ajt.15399.
    [16] CHAVIN KD, TABER DJ, NORCROSS M, et al. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm[J]. Clin Transplant, 2013, 27(5): 732-741. DOI: 10.1111/ctr.12211.
    [17] TRAKROO S, BHARDWAJ N, GARG R, et al. Weight loss interventions in living donor liver transplantation as a tool in expanding the donor pool: a systematic review and meta-analysis[J]. World J Gastroenterol, 2021, 27(24): 3682-3692. DOI: 10.3748/wjg.v27.i24.3682.
    [18] CHEN Z, MA Y, DONG Y, et al. Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis[J]. PeerJ, 2023, 11: e15620. DOI: 10.7717/peerj.15620.
    [19] ALI SE, VUTIEN P, BONHAM CA, et al. Use and outcomes of hepatitis B virus-positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021[J]. Liver Transpl, 2023, 29(1): 80-90. DOI: 10.1002/lt.26543.
    [20] GANG S, CHOI Y, LEE B, et al. Long-term outcomes of liver transplantation using grafts from donors with active hepatitis B virus replication: a multicenter cohort study[J]. Ann Surg Treat Res, 2023, 104(4): 183-194. DOI: 10.4174/astr.2023.104.4.183.
    [21] DHALIWAL A, DHINDSA B, RAMAI D, et al. Impact of utilization of hepatitis C positive organs in liver transplant: analysis of united network for organ sharing database[J]. World J Hepatol, 2022, 14(5): 984-991. DOI: 10.4254/wjh.v14.i5.984.
    [22] LEGAZ I, MURO M. Analysis of hepatitis C virus-positive organs in liver transplantation[J]. World J Hepatol, 2022, 14(9): 1840-1843. DOI: 10.4254/wjh.v14.i9.1840.
    [23] LYMBEROPOULOS P, SHAIKH A, RICH NE, et al. Comparable survival for hepatitis C-related hepatocellular carcinoma after liver transplantation irrespective of viremic status[J]. Clin Gastroenterol Hepatol, 2023, 21(5): 1362-1364. DOI: 10.1016/j.cgh.2022.03.021.
    [24] BEKKI Y, CRISMALE JF, MYERS B, et al. Varying utilization rates but superior outcomes in liver transplantation from hepatitis c-positive donors in the united states: an analysis of the OPTN/UNOS database[J]. Transplantation, 2022, 106(9): 1787-1798. DOI: 10.1097/TP.0000000000004116.
    [25] MYERS B, BEKKI Y, KOZATO A, et al. DCD hepatitis C virus-positive donor livers can achieve favorable outcomes with liver transplantation and are underutilized[J]. Transplantation, 2023, 107(3): 670-679. DOI: 10.1097/TP.0000000000004401.
    [26] 易述红. 劈离式肝移植的现状和发展[J]. 肝胆外科杂志, 2022, 30(6): 474-476. DOI: 10.3969/j.issn.1006-4761.2022.06.019.

    YI SH. The current situation and development of split liver transplantation[J]. J Hepatobiliary Surg, 2022, 30(6): 474-476. DOI: 10.3969/j.issn.1006-4761.2022.06.019.
    [27] WAN P, LI Q, ZHANG J, et al. Right lobe split liver transplantation versus whole liver transplantation in adult recipients: a systematic review and meta-analysis[J]. Liver Transpl, 2015, 21(7): 928-943. DOI: 10.1002/lt.24135.
    [28] 孙延东, 滕大洪, 王峰, 等. 劈离式肝移植与全肝移植的临床队列研究[J]. 中华外科杂志, 2023, 61(10): 856-862. DOI: 10.3760/cma.j.cn112139-20230601-00220.

    SUN YD, TENG DH, WANG F, et al. A clinical cohort study of split and whole liver transplantations[J]. Chin J Surg, 2023, 61(10): 856-862. DOI: 10.3760/cma.j.cn112139-20230601-00220.
    [29] ANDRASSY J, WOLF S, LAUSEKER M, et al. Higher retransplantation rate following extended right split-liver transplantation: an analysis from the eurotransplant liver follow-up registry[J]. Liver Transpl, 2018, 24(1): 26-34. DOI: 10.1002/lt.24980.
    [30] MCELROY LM, MARTIN AE, FELDMAN AG, et al. An appraisal of technical variant grafts compared to whole liver grafts in pediatric liver transplant recipients: multicenter analysis from the SPLIT registry[J]. Pediatr Transplant, 2023, 27(1): e14415. DOI: 10.1111/petr.14415.
    [31] PERKINS JD, DICK AA, HEALEY PJ, et al. New evidence supporting increased use of split liver transplantation[J]. Transplantation, 2020, 104(2): 299-307. DOI: 10.1097/TP.0000000000002853.
    [32] 中国医师协会器官移植医师分会, 中华医学会器官移植学分会, 中华医学会外科学分会移植学组, 等. 中国心脏死亡捐献器官评估与应用专家共识(2022版)[J]. 中华消化外科杂志, 2022, 21(12): 1491-1498. DOI: 10.3760/cma.j.cn115610-20221115-00690.

    Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, Branch of Organ Transplantation of Chinese Medical Association, Division of Organ Transplantation of Branch of Surgery of Chinese Medical Association, et al. Expert consensus on evaluation and application of organs donated after cardiac death in China (2022 edition)[J]. Chin J Dig Surg, 2022, 21(12): 1491-1498. DOI: 10.3760/cma.j.cn115610-20221115-00690.
    [33] 杨洋, 矫宁, 陈新国, 等. 心脏死亡者供肝移植术后受体早期肝功能恢复不良的影响因素分析[J]. 武警医学, 2021, 32(9): 790-794. DOI: 10.3969/j.issn.1004-3594.2021.09.013.

    YANG Y, JIAO N, CHEN XG, et al. Analysis of influencing factors of early poor recovery of liver function after liver trans-plantation with organ donation for cardiac death[J]. Med J Chin PAP, 2021, 32(9): 790-794. DOI: 10.3969/j.issn.1004-3594.2021.09.013.
    [34] 邹欣蕾, 黄子越, 史武江, 等. 常温局部灌注在受控心脏死亡肝移植供体中的应用[J]. 中国普通外科杂志, 2023, 32(7): 1087-1096. DOI: 10.7659/j.issn.1005-6947.2023.07.014.

    ZOU XL, HUANG ZY, SHI WJ, et al. Application of normothermic regional perfusion in controlled donation after cardiac death liver transplant donors[J]. Chin J Gen Surg, 2023, 32(7): 1087-1096. DOI: 10.7659/j.issn.1005-6947.2023.07.014.
    [35] PANCONESI R, CARVALHO MF, MUIESAN P, et al. Liver perfusion strategies: what is best and do ischemia times still matter?[J]. Curr Opin Organ Transplant, 2022, 27(4): 285-299. DOI: 10.1097/MOT.0000000000000963.
    [36] ELMER A, ROHRER ML, BENDEN C, et al. Organ donation after circulatory death as compared with organ donation after brain death in Switzerland - an observational study[J]. Swiss Med Wkly, 2022, 152: w30139. DOI: 10.4414/smw.2022.w30132.
    [37] MAZILESCU LI, KOTHA S, GHANEKAR A, et al. Early allograft dysfunction after liver transplantation with donation after circulatory death and brain death grafts: does the donor type matter?[J]. Transplant Direct, 2021, 7(8): e727. DOI: 10.1097/TXD.0000000000 001182.
    [38] CROOME KP, MATHUR AK, LEE DD, et al. Outcomes of donation after circulatory death liver grafts from donors 50 years or older: a multicenter analysis[J]. Transplantation, 2018, 102(7): 1108-1114. DOI: 10.1097/ TP.0000000000002120.
    [39] HARRING TR, NGUYEN NT, COTTON RT, et al. Liver transplantation with donation after cardiac death donors: a comprehensive update[J]. J Surg Res, 2012, 178(1): 502-511. DOI: 10.1016/j.jss.2012.04.044.
    [40] LIMKEMANN AJ, SINGH N, HELFRICH K, et al. Safely expanding the liver donor pool by utilization of organs from donation after circulatory death with comparable results to donation after brain death, a large single-center experience[J]. J Gastrointest Surg, 2022, 26(7): 1453-1461. DOI: 10.1007/s11605-022-05313-0.
    [41] SCHLEGEL A, VAN REEVEN M, CROOME K, et al. A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation[J]. J Hepatol, 2022, 76(2): 371-382. DOI: 10.1016/j.jhep.2021.10.004.
    [42] MCCORMACK L, QUIÑONEZ E, RÍOS MM, et al. Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'[J]. HPB (Oxford), 2010, 12(8): 523-530. DOI: 10.1111/j.1477-2574.2010.00193.x.
    [43] RAUCHFUß F, TAUTENHAHN HM, DONDORF F, et al. Critical evaluation of discarded donor livers in the eurotransplant region: potential implications for machine perfusion[J]. Ann Transplant, 2023, 28: e938132. DOI: 10.12659/AOT.938132.
    [44] AHMED O, XU M, ZHOU F, et al. NRF2 assessment in discarded liver allografts: a role in allograft function and salvage[J]. Am J Transplant, 2022, 22(1): 58-70. DOI: 10.1111/ajt.16789.
    [45] 汪恺, 苏仁义, 王周城, 等. “机械灌注+”视阈下扩大标准供肝的修复与功能提升[J]. 中华消化外科杂志, 2022, 21(1): 74-78. DOI: 10.3760/cma.j.cn115610-20211220-00668.

    WANG K , SU RY, WANG ZC, et al. Extended criteria donor reconditioning and functional improvement in the viewshed of machine perfusion plus[J]. Chin J Dig Surg, 2022, 21(1): 74-78. DOI: 10.3760/cma.j.cn115610-20211220-00668.
    [46] 贾俊君, 李建辉, 郑树森. “陆止于此, 海始于斯”: 机械灌注将成为供肝保存修复新常态[J/CD]. 中华移植杂志(电子版), 2018, 12(3): 102-105. DOI: 10.3877/cma.j.issn.1674-3903.2018.03.002.

    JIA JJ, LI JH, ZHENG SS. "Land ends here, sea begins here": machine perfusion becomes the new normal for liver graft preservation[J/CD]. Chin J Transplant (Electr Edit) , 2018, 12(3): 102-105. DOI: 10.3877/cma.j.issn.1674-3903.2018.03.002.
    [47] OLUMBA FC, ZHOU F, PARK Y, et al. Normothermic machine perfusion for declined livers: a strategy to rescue marginal livers for transplantation[J]. J Am Coll Surg, 2023, 236(4): 614-625. DOI: 10.1097/XCS.0000000000000555.
    [48] LASCARIS B, DE MEIJER VE, PORTE RJ. Normothermic liver machine perfusion as a dynamic platform for regenerative purposes: what does the future have in store for us?[J]. J Hepatol, 2022, 77(3): 825-836. DOI: 10.1016/j.jhep.2022.04.033.
    [49] ESHMUMINOV D, MUELLER M, BRUGGER SD, et al. Sources and prevention of graft infection during long-term ex situ liver perfusion[J]. Transpl Infect Dis, 2021, 23(4): e13623. DOI: 10.1111/tid.13623.
    [50] 朱财慧, 汪琳和, 张志衡, 等. 常温机械灌注修复边缘性供肝的临床疗效: 单中心报道[J/CD]. 中华普通外科学文献(电子版), 2020, 14(4): 280-285. DOI: 10.3877/cma.j.issn.1674-0793.2020.04.010.

    ZHU HC, WANG LH, ZHANG ZH, et al. Clinical outcomes of liver transplantation using normothermic machine perfusion: a single center report[J/CD]. Chin Arch Gen Surg (Electr Edit) , 2020, 14(4): 280-285. DOI: 10.3877/cma.j.issn.1674-0793.2020.04.010.
    [51] LIU Q, DEL PRETE L, ALI K, et al. Sequential hypothermic and normothermic perfusion preservation and transplantation of expanded criteria donor livers[J]. Surgery, 2023, 173(3): 846-854. DOI: 10.1016/j.surg.2022.07.035.
    [52] CZIGANY Z, PRATSCHKE J, FRONĚK J, et al. Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD)[J]. Ann Surg, 2021, 274(5): 705-712. DOI: 10.1097/SLA.0000000000005110.
  • 加载中
计量
  • 文章访问数:  21
  • HTML全文浏览量:  16
  • PDF下载量:  9
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-01-02
  • 网络出版日期:  2024-02-29

目录

    /

    返回文章
    返回